These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 15153482)

  • 1. Duration of alloantigen presentation and avidity of T cell antigen recognition correlate with immunodominance of CTL response to minor histocompatibility antigens.
    Yoshimura Y; Yadav R; Christianson GJ; Ajayi WU; Roopenian DC; Joyce S
    J Immunol; 2004 Jun; 172(11):6666-74. PubMed ID: 15153482
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunodominance in the CTL response against minor histocompatibility antigens: interference between responding T cells, rather than with presentation of epitopes.
    Wolpert EZ; Grufman P; Sandberg JK; Tegnesjö A; Kärre K
    J Immunol; 1998 Nov; 161(9):4499-505. PubMed ID: 9794374
    [TBL] [Abstract][Full Text] [Related]  

  • 3. On the mechanisms of immunodominance in cytotoxic T lymphocyte responses to minor histocompatibility antigens.
    Pion S; Fontaine P; Desaulniers M; Jutras J; Filep JG; Perreault C
    Eur J Immunol; 1997 Feb; 27(2):421-30. PubMed ID: 9045913
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Few peptides dominate cytotoxic T lymphocyte responses to single and multiple minor histocompatibility antigens.
    Yin L; Poirier G; Neth O; Hsuan JJ; Totty NF; Stauss HJ
    Int Immunol; 1993 Sep; 5(9):1003-9. PubMed ID: 7694638
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative analysis of the immune response to mouse non-MHC transplantation antigens in vivo: the H60 histocompatibility antigen dominates over all others.
    Choi EY; Yoshimura Y; Christianson GJ; Sproule TJ; Malarkannan S; Shastri N; Joyce S; Roopenian DC
    J Immunol; 2001 Apr; 166(7):4370-9. PubMed ID: 11254691
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunization with dendritic cells breaks immunodominance in CTL responses against minor histocompatibility and synthetic peptide antigens.
    Grufman P; Sandberg JK; Wolpert EZ; Kärre K
    J Leukoc Biol; 1999 Aug; 66(2):268-71. PubMed ID: 10449165
    [TBL] [Abstract][Full Text] [Related]  

  • 7. T cell competition for the antigen-presenting cell as a model for immunodominance in the cytotoxic T lymphocyte response against minor histocompatibility antigens.
    Grufman P; Wolpert EZ; Sandberg JK; Kärre K
    Eur J Immunol; 1999 Jul; 29(7):2197-204. PubMed ID: 10427982
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary vascularization of the graft determines the immunodominance of murine minor H antigens during organ transplantation.
    Kwun J; Malarkannan S; Burlingham WJ; Knechtle SJ
    J Immunol; 2011 Oct; 187(8):3997-4006. PubMed ID: 21900176
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of the role of MHC class II presentation in the stimulation of cytotoxic T lymphocytes by antigens targeted into the exogenous antigen-MHC class I presentation pathway.
    Rock KL; Clark K
    J Immunol; 1996 May; 156(10):3721-6. PubMed ID: 8621907
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An immunodominant minor histocompatibility alloantigen that initiates corneal allograft rejection.
    Haskova Z; Sproule TJ; Roopenian DC; Ksander AB
    Transplantation; 2003 Apr; 75(8):1368-74. PubMed ID: 12717232
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differences that matter: major cytotoxic T cell-stimulating minor histocompatibility antigens.
    Malarkannan S; Horng T; Eden P; Gonzalez F; Shih P; Brouwenstijn N; Klinge H; Christianson G; Roopenian D; Shastri N
    Immunity; 2000 Sep; 13(3):333-44. PubMed ID: 11021531
    [TBL] [Abstract][Full Text] [Related]  

  • 12. T lymphocyte responses to multiple minor histocompatibility antigens generate both self-major histocompatibility complex-restricted and cross-reactive cytotoxic T lymphocytes.
    Tremblay N; Fontaine P; Perreault C
    Transplantation; 1994 Jul; 58(1):59-67. PubMed ID: 8036709
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Avidity of CD8 T cells sharpens immunodominance.
    Dzutsev AH; Belyakov IM; Isakov DV; Margulies DH; Berzofsky JA
    Int Immunol; 2007 Apr; 19(4):497-507. PubMed ID: 17376783
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The murine cytomegalovirus immunomodulatory gene m152 prevents recognition of infected cells by M45-specific CTL but does not alter the immunodominance of the M45-specific CD8 T cell response in vivo.
    Gold MC; Munks MW; Wagner M; Koszinowski UH; Hill AB; Fling SP
    J Immunol; 2002 Jul; 169(1):359-65. PubMed ID: 12077265
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Minor histocompatibility antigens: presentation principles, recognition logic and the potential for a healing hand.
    Spencer CT; Gilchuk P; Dragovic SM; Joyce S
    Curr Opin Organ Transplant; 2010 Aug; 15(4):512-25. PubMed ID: 20616723
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential binding of a minor histocompatibility antigen peptide to H-2 class I molecules correlates with immune responsiveness.
    Wettstein PJ; van Bleek GM; Nathenson SG
    J Immunol; 1993 Apr; 150(7):2753-60. PubMed ID: 7681080
    [TBL] [Abstract][Full Text] [Related]  

  • 17. T-cell mediated responses in a murine model of orthotopic corneal transplantation.
    Joo CK; Pepose JS; Stuart PM
    Invest Ophthalmol Vis Sci; 1995 Jul; 36(8):1530-40. PubMed ID: 7601633
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recognition of clonogenic leukemic cells, remission bone marrow and HLA-identical donor bone marrow by CD8+ or CD4+ minor histocompatibility antigen-specific cytotoxic T lymphocytes.
    Faber LM; van der Hoeven J; Goulmy E; Hooftman-den Otter AL; van Luxemburg-Heijs SA; Willemze R; Falkenburg JH
    J Clin Invest; 1995 Aug; 96(2):877-83. PubMed ID: 7635982
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The major histocompatibility complex determines susceptibility to cytotoxic T cells directed against minor histocompatibility antigens. 1975.
    Bevan MJ
    J Immunol; 2005 Dec; 175(11):7069-84. PubMed ID: 16301608
    [No Abstract]   [Full Text] [Related]  

  • 20. A novel HLA-A*3303-restricted minor histocompatibility antigen encoded by an unconventional open reading frame of human TMSB4Y gene.
    Torikai H; Akatsuka Y; Miyazaki M; Warren EH; Oba T; Tsujimura K; Motoyoshi K; Morishima Y; Kodera Y; Kuzushima K; Takahashi T
    J Immunol; 2004 Dec; 173(11):7046-54. PubMed ID: 15557202
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.